<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03082911</url>
  </required_header>
  <id_info>
    <org_study_id>Corporació Parc Taulí</org_study_id>
    <nct_id>NCT03082911</nct_id>
  </id_info>
  <brief_title>A Telephone Intervention to Improve Participation in a Screening Program.</brief_title>
  <official_title>Effectiveness of a Brief Telephone Intervention to Improve Participation in a Colorectal Cancer Screening Program: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corporacion Parc Tauli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Corporacion Parc Tauli</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: To assess the effectiveness of a brief telephone intervention added to an post
      invitation letter in the participation rate to a colorectal cancer screening program.

      Methods: Randomized controlled trial. This study is framed inside the colorectal cancer
      screening program of Catalonia, concretely in the region of Vallès Occidental. This program
      is directed to men and women from 50 to 69 years. The screening test used is the fecal
      immunological test (FIT) that is offered every 2 years. If the screening test is positive, a
      colonoscopy with sedation is offered as a diagnostic test.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 13, 2017</start_date>
  <completion_date type="Actual">December 20, 2017</completion_date>
  <primary_completion_date type="Actual">July 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Participation</measure>
    <time_frame>6 months</time_frame>
    <description>Participation is defined as the number of people who do the screening test to the total of people invited to the Program.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Knowledge of the program</measure>
    <time_frame>1 day at the time of intervention administration</time_frame>
    <description>proportion of people from the intervention group who report knowing the existence of the program.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comprehension of the information received</measure>
    <time_frame>1 day at the time of intervention administration</time_frame>
    <description>proportion of people from the intervention group who report having understood in which the screening program consists of.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Help to decide about participation</measure>
    <time_frame>1 day at the time of intervention administration</time_frame>
    <description>proportion of people from the intervention group who report that the information received in the phone call will be useful to decide about their participation in the program.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">432</enrollment>
  <condition>Colorectal Cancer</condition>
  <condition>Colorectal Neoplasms</condition>
  <arm_group>
    <arm_group_label>Phone call</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A brief telephone intervention at the same time of sending the invitation letter plus the habitual invitation process used in the screening program (described in control group).
Calls will be made by the administrative staff of the Screening Technical Office, which is experienced in telephone attention.
Each phone call will last approximately 5 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard procedure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The habitual invitation strategy used in the screening program . Three letters are send by post: 1- An invitation letter plus an information leaflet and a list of pharmacies in which people can obtain the screening test. 2- A reminder letter for those who have not participated after 5 weeks of sending the first letter. 3- A second reminder letter for those who have collected the kit in the pharmacy but have not returned it with the sample.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Phone call</intervention_name>
    <description>A brief telephone intervention at the same time of sending the invitation letter plus the habitual invitation process used in the screening program (described in control group). Each phone call will last approximately 5 minutes.
Calls will be made by the administrative staff of the Screening Technical Office, which is experienced in telephone attention.</description>
    <arm_group_label>Phone call</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Invitation letter</intervention_name>
    <description>The habitual invitation strategy used in the screening program . Three letters are send by post: 1- An invitation letter plus an information leaflet and a list of pharmacies in which people can obtain the screening test. 2- A reminder letter for those who have not participated after 5 weeks of sending the first letter. 3- A second reminder letter for those who have collected the kit in the pharmacy but have not returned it with the sample</description>
    <arm_group_label>Phone call</arm_group_label>
    <arm_group_label>Standard procedure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women and men from 50 to 69 years living in the selected territories (Terrassa C,
             Terrassa A, Cerdanyola del Vallès 1) that will be invited for the first time in the
             Colorectal cancer screening program.

        Exclusion Criteria:

          -  The same as those used in the population program:

               1. History of colorectal cancer;

               2. History of inflammatory bowel disease;

               3. history of colorectal adenomas;

               4. family history of polyposis syndromes or hereditary nonpolyposis colorectal
                  cancer;

               5. family history of colorectal cancer if: two first grade relatives affected or
                  only one fist grade relative affected diagnosed before the age of 60;

               6. terminal illness or severe disability which contraindicates the study of the
                  colon. People is excluded temporally if:

                    -  1) they have a colonoscopy performed in the last 5 years;

                    -  2) present digestive signs or symptoms (rectal bleeding, change in bowel
                       habits, abdominal pain, weight loss with fatigue and anorexia, abdominal
                       mass);

                    -  3) they express the will to be out of the Program.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>49 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Corporació Sanitària Parc Taulí</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>March 13, 2017</study_first_submitted>
  <study_first_submitted_qc>March 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 17, 2017</study_first_posted>
  <last_update_submitted>January 29, 2019</last_update_submitted>
  <last_update_submitted_qc>January 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Corporacion Parc Tauli</investigator_affiliation>
    <investigator_full_name>Anna Selva</investigator_full_name>
    <investigator_title>Medical doctor specialist in Preventive Medicine and Public Health</investigator_title>
  </responsible_party>
  <keyword>screening</keyword>
  <keyword>early detection</keyword>
  <keyword>participation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

